This leaflet is about the use of atenolol for high blood pressure (which is also called hypertension). Wash‐out periods on a matching placebo were included between the treatment periods. Atenolol for hypertension. Most outcome RCTs on beta-blockers as initial therapy for hypertension have high risk of bias. To read this article in full you will need to make a payment2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.Medical Research Council trial of treatment of hypertension in older adults: principal results.Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39.Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.The Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rational, and outline protocol.Beta-blockers in hypertension: the emperor has no clothes—an open letter to present and prospective drafters of new guidelines for the treatment of hypertension.Might losartan reduce sudden cardiac death in diabetic patients with hypertension?.β blockade after myocardial infarction: systematic review and meta regression analysis.Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension).Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP).Randomised trial of effects of calcium antagonists compared with diuretics and β blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial.A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. Each patient received atenolol (50 mg/day, 100 mg/day, 200 mg/day) and placebo according to a randomized sequence in a once‐daily dose. Name must be less than 100 characters 2010 May;9(5):469-80. doi: 10.1016/S1474-4422(10)70066-1. Clipboard, Search History, and several other advanced features are temporarily unavailable. 2005 Oct 29-Nov 4;366(9496):1545-53. doi: 10.1016/S0140-6736(05)67573-3.Adv Exp Med Biol. The mean supine and erect arterial pressures of the 16 patients completing the run‐in period were markedly reduced by atenolol therapy. Epub 2010 Mar 11.van den Born BJ, Brewster LM, Koopmans RP, van Montfrans GA.Dahlöf B, Devereux RB, Kjeldsen SE, Lyle PA, Zhang Z, Edelman JM.Blood Press. Eighteen patients were started on atenolol, 75 mg/day; the dose was increased at 2‐wk intervals to a maximum of 900 mg if tolerated. Metoprolol is also used to prevent migraines. Part A: Theory and Practice, A dose-response study of atenolol in mild to moderate hypertension in general practice, Dose-response relationships with antihypertensive drugs, Determination of Beta-Blockers in Biological Material, Effects of atenolol on 24-hour arterial pressure and heart rate in essential hypertension, Effects of atenolol and hydrochlorothiazide on blood pressure and plasma catecholamines in essential hypertension., Atenolol and Timolol, Two New Systemic β-Adrenoceptor Antagonists, European Journal of Drug Metabolism and Pharmacokinetics, Long-term benefit of cardioselective beta blockade with once-daily atenolol therapy in angina pectoris, Sotalol and metoprolol comparison of their anti-hypertensive effect, Clinical evaluation of atenolol in hypertensive patients., Use of fixed doses of beta blocking drugs in the treatment of hypertension, Effect of atenolol on left ventricular function in hypertensive patients., Dosage dans les milieux biologiques d'un nouveau bèta-bloquant, l'aténoiol, par chromatographie liquide haute performance, Studies on the pharmacokinetics and pharmacodynamics of atenolol in man, A comparison of once and twice daily atenolol in hypertension., © 2020 American Society for Clinical Pharmacology and Therapeutics Atenolol is one of the most widely used β blockers clinically, and has often been used as a reference drug in randomised controlled trials of hypertension. If you do not receive an email within 10 minutes, your email address may not be registered,